[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Irritable Bowel Syndrome (IBS) Market - Global Outlook and Forecast 2021-2027

January 2021 | 94 pages | ID: I51452F4F6CEEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Irritable Bowel Syndrome (IBS) in global, including the following market information:
Global Irritable Bowel Syndrome (IBS) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Irritable Bowel Syndrome (IBS) Market Sales, 2016-2021, 2022-2027, (Million Units)
Global top five Irritable Bowel Syndrome (IBS) companies in 2020 (%)
The global Irritable Bowel Syndrome (IBS) market was valued at 3441.8 million in 2020 and is projected to reach US$ 4557.8 million by 2027, at a CAGR of 7.3% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Irritable Bowel Syndrome (IBS) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Irritable Bowel Syndrome (IBS) Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Million Units)
Global Irritable Bowel Syndrome (IBS) Market Segment Percentages, By Type, 2020 (%)
  • IBS-D Drug
  • IBS-C Drug
  • Other
Global Irritable Bowel Syndrome (IBS) Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Million Units)
Global Irritable Bowel Syndrome (IBS) Market Segment Percentages, By Application, 2020 (%)
  • Women
  • Men
Global Irritable Bowel Syndrome (IBS) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (Million Units)
Global Irritable Bowel Syndrome (IBS) Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Irritable Bowel Syndrome (IBS) revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Irritable Bowel Syndrome (IBS) revenues share in global market, 2020 (%)
Key companies Irritable Bowel Syndrome (IBS) sales in global market, 2016-2021 (Estimated), (Million Units)
Key companies Irritable Bowel Syndrome (IBS) sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Bausch Health
  • Allergan
  • Takeda
  • Sucampo Pharmaceuticals (Mallinckrodt)
  • Sebela Pharmaceuticals Inc
  • Astellas Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Irritable Bowel Syndrome (IBS) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Irritable Bowel Syndrome (IBS) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) OVERALL MARKET SIZE

2.1 Global Irritable Bowel Syndrome (IBS) Market Size: 2021 VS 2027
2.2 Global Irritable Bowel Syndrome (IBS) Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Irritable Bowel Syndrome (IBS) Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Irritable Bowel Syndrome (IBS) Players in Global Market
3.2 Top Global Irritable Bowel Syndrome (IBS) Companies Ranked by Revenue
3.3 Global Irritable Bowel Syndrome (IBS) Revenue by Companies
3.4 Global Irritable Bowel Syndrome (IBS) Sales by Companies
3.5 Global Irritable Bowel Syndrome (IBS) Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Irritable Bowel Syndrome (IBS) Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Irritable Bowel Syndrome (IBS) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Irritable Bowel Syndrome (IBS) Players in Global Market
  3.8.1 List of Global Tier 1 Irritable Bowel Syndrome (IBS) Companies
  3.8.2 List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome (IBS) Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Irritable Bowel Syndrome (IBS) Market Size Markets, 2021 & 2027
  4.1.2 IBS-D Drug
  4.1.3 IBS-C Drug
  4.1.4 Other
4.2 By Type - Global Irritable Bowel Syndrome (IBS) Revenue & Forecasts
  4.2.1 By Type - Global Irritable Bowel Syndrome (IBS) Revenue, 2016-2021
  4.2.2 By Type - Global Irritable Bowel Syndrome (IBS) Revenue, 2022-2027
  4.2.3 By Type - Global Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
4.3 By Type - Global Irritable Bowel Syndrome (IBS) Sales & Forecasts
  4.3.1 By Type - Global Irritable Bowel Syndrome (IBS) Sales, 2016-2021
  4.3.2 By Type - Global Irritable Bowel Syndrome (IBS) Sales, 2022-2027
  4.3.3 By Type - Global Irritable Bowel Syndrome (IBS) Sales Market Share, 2016-2027
4.4 By Type - Global Irritable Bowel Syndrome (IBS) Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Irritable Bowel Syndrome (IBS) Market Size, 2021 & 2027
  5.1.2 Women
  5.1.3 Men
5.2 By Application - Global Irritable Bowel Syndrome (IBS) Revenue & Forecasts
  5.2.1 By Application - Global Irritable Bowel Syndrome (IBS) Revenue, 2016-2021
  5.2.2 By Application - Global Irritable Bowel Syndrome (IBS) Revenue, 2022-2027
  5.2.3 By Application - Global Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
5.3 By Application - Global Irritable Bowel Syndrome (IBS) Sales & Forecasts
  5.3.1 By Application - Global Irritable Bowel Syndrome (IBS) Sales, 2016-2021
  5.3.2 By Application - Global Irritable Bowel Syndrome (IBS) Sales, 2022-2027
  5.3.3 By Application - Global Irritable Bowel Syndrome (IBS) Sales Market Share, 2016-2027
5.4 By Application - Global Irritable Bowel Syndrome (IBS) Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Irritable Bowel Syndrome (IBS) Market Size, 2021 & 2027
6.2 By Region - Global Irritable Bowel Syndrome (IBS) Revenue & Forecasts
  6.2.1 By Region - Global Irritable Bowel Syndrome (IBS) Revenue, 2016-2021
  6.2.2 By Region - Global Irritable Bowel Syndrome (IBS) Revenue, 2022-2027
  6.2.3 By Region - Global Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
6.3 By Region - Global Irritable Bowel Syndrome (IBS) Sales & Forecasts
  6.3.1 By Region - Global Irritable Bowel Syndrome (IBS) Sales, 2016-2021
  6.3.2 By Region - Global Irritable Bowel Syndrome (IBS) Sales, 2022-2027
  6.3.3 By Region - Global Irritable Bowel Syndrome (IBS) Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Irritable Bowel Syndrome (IBS) Revenue, 2016-2027
  6.4.2 By Country - North America Irritable Bowel Syndrome (IBS) Sales, 2016-2027
  6.4.3 US Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.4.4 Canada Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.4.5 Mexico Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Irritable Bowel Syndrome (IBS) Revenue, 2016-2027
  6.5.2 By Country - Europe Irritable Bowel Syndrome (IBS) Sales, 2016-2027
  6.5.3 Germany Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.5.4 France Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.5.5 U.K. Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.5.6 Italy Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.5.7 Russia Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.5.8 Nordic Countries Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.5.9 Benelux Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Irritable Bowel Syndrome (IBS) Revenue, 2016-2027
  6.6.2 By Region - Asia Irritable Bowel Syndrome (IBS) Sales, 2016-2027
  6.6.3 China Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.6.4 Japan Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.6.5 South Korea Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.6.6 Southeast Asia Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.6.7 India Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Irritable Bowel Syndrome (IBS) Revenue, 2016-2027
  6.7.2 By Country - South America Irritable Bowel Syndrome (IBS) Sales, 2016-2027
  6.7.3 Brazil Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.7.4 Argentina Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Irritable Bowel Syndrome (IBS) Sales, 2016-2027
  6.8.3 Turkey Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.8.4 Israel Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.8.5 Saudi Arabia Irritable Bowel Syndrome (IBS) Market Size, 2016-2027
  6.8.6 UAE Irritable Bowel Syndrome (IBS) Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Bausch Health
  7.1.1 Bausch Health Corporate Summary
  7.1.2 Bausch Health Business Overview
  7.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Major Product Offerings
  7.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Sales and Revenue in Global (2016-2021)
  7.1.5 Bausch Health Key News
7.2 Allergan
  7.2.1 Allergan Corporate Summary
  7.2.2 Allergan Business Overview
  7.2.3 Allergan Irritable Bowel Syndrome (IBS) Major Product Offerings
  7.2.4 Allergan Irritable Bowel Syndrome (IBS) Sales and Revenue in Global (2016-2021)
  7.2.5 Allergan Key News
7.3 Takeda
  7.3.1 Takeda Corporate Summary
  7.3.2 Takeda Business Overview
  7.3.3 Takeda Irritable Bowel Syndrome (IBS) Major Product Offerings
  7.3.4 Takeda Irritable Bowel Syndrome (IBS) Sales and Revenue in Global (2016-2021)
  7.3.5 Takeda Key News
7.4 Sucampo Pharmaceuticals (Mallinckrodt)
  7.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Corporate Summary
  7.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
  7.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Major Product Offerings
  7.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales and Revenue in Global (2016-2021)
  7.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Key News
7.5 Sebela Pharmaceuticals Inc
  7.5.1 Sebela Pharmaceuticals Inc Corporate Summary
  7.5.2 Sebela Pharmaceuticals Inc Business Overview
  7.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Major Product Offerings
  7.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales and Revenue in Global (2016-2021)
  7.5.5 Sebela Pharmaceuticals Inc Key News
7.6 Astellas Pharmaceuticals
  7.6.1 Astellas Pharmaceuticals Corporate Summary
  7.6.2 Astellas Pharmaceuticals Business Overview
  7.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Major Product Offerings
  7.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales and Revenue in Global (2016-2021)
  7.6.5 Astellas Pharmaceuticals Key News

8 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) PRODUCTION CAPACITY, ANALYSIS

8.1 Global Irritable Bowel Syndrome (IBS) Production Capacity, 2016-2027
8.2 Irritable Bowel Syndrome (IBS) Production Capacity of Key Manufacturers in Global Market
8.3 Global Irritable Bowel Syndrome (IBS) Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 IRRITABLE BOWEL SYNDROME (IBS) SUPPLY CHAIN ANALYSIS

10.1 Irritable Bowel Syndrome (IBS) Industry Value Chain
10.2 Irritable Bowel Syndrome (IBS) Upstream Market
10.3 Irritable Bowel Syndrome (IBS) Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Irritable Bowel Syndrome (IBS) Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Irritable Bowel Syndrome (IBS) in Global Market
Table 2. Top Irritable Bowel Syndrome (IBS) Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Irritable Bowel Syndrome (IBS) Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Irritable Bowel Syndrome (IBS) Revenue Share by Companies, 2016-2021
Table 5. Global Irritable Bowel Syndrome (IBS) Sales by Companies, (Million Units), 2016-2021
Table 6. Global Irritable Bowel Syndrome (IBS) Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Irritable Bowel Syndrome (IBS) Price (2016-2021) & (USD/K Units)
Table 8. Global Manufacturers Irritable Bowel Syndrome (IBS) Product Type
Table 9. List of Global Tier 1 Irritable Bowel Syndrome (IBS) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome (IBS) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Irritable Bowel Syndrome (IBS) Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Irritable Bowel Syndrome (IBS) Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Irritable Bowel Syndrome (IBS) Sales (Million Units), 2016-2021
Table 15. By Type - Global Irritable Bowel Syndrome (IBS) Sales (Million Units), 2022-2027
Table 16. By Application – Global Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Irritable Bowel Syndrome (IBS) Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Irritable Bowel Syndrome (IBS) Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Irritable Bowel Syndrome (IBS) Sales (Million Units), 2016-2021
Table 20. By Application - Global Irritable Bowel Syndrome (IBS) Sales (Million Units), 2022-2027
Table 21. By Region – Global Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Irritable Bowel Syndrome (IBS) Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Irritable Bowel Syndrome (IBS) Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Irritable Bowel Syndrome (IBS) Sales (Million Units), 2016-2021
Table 25. By Region - Global Irritable Bowel Syndrome (IBS) Sales (Million Units), 2022-2027
Table 26. By Country - North America Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Irritable Bowel Syndrome (IBS) Sales, (Million Units), 2016-2021
Table 29. By Country - North America Irritable Bowel Syndrome (IBS) Sales, (Million Units), 2022-2027
Table 30. By Country - Europe Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Irritable Bowel Syndrome (IBS) Sales, (Million Units), 2016-2021
Table 33. By Country - Europe Irritable Bowel Syndrome (IBS) Sales, (Million Units), 2022-2027
Table 34. By Region - Asia Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Irritable Bowel Syndrome (IBS) Sales, (Million Units), 2016-2021
Table 37. By Region - Asia Irritable Bowel Syndrome (IBS) Sales, (Million Units), 2022-2027
Table 38. By Country - South America Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Irritable Bowel Syndrome (IBS) Sales, (Million Units), 2016-2021
Table 41. By Country - South America Irritable Bowel Syndrome (IBS) Sales, (Million Units), 2022-2027
Table 42. By Country - Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Irritable Bowel Syndrome (IBS) Sales, (Million Units), 2016-2021
Table 45. By Country - Middle East & Africa Irritable Bowel Syndrome (IBS) Sales, (Million Units), 2022-2027
Table 46. Bausch Health Corporate Summary
Table 47. Bausch Health Irritable Bowel Syndrome (IBS) Product Offerings
Table 48. Bausch Health Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2016-2021)
Table 49. Allergan Corporate Summary
Table 50. Allergan Irritable Bowel Syndrome (IBS) Product Offerings
Table 51. Allergan Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2016-2021)
Table 52. Takeda Corporate Summary
Table 53. Takeda Irritable Bowel Syndrome (IBS) Product Offerings
Table 54. Takeda Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2016-2021)
Table 55. Sucampo Pharmaceuticals (Mallinckrodt) Corporate Summary
Table 56. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Offerings
Table 57. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2016-2021)
Table 58. Sebela Pharmaceuticals Inc Corporate Summary
Table 59. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Offerings
Table 60. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2016-2021)
Table 61. Astellas Pharmaceuticals Corporate Summary
Table 62. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offerings
Table 63. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2016-2021)
Table 64. Irritable Bowel Syndrome (IBS) Production Capacity (Million Units) of Key Manufacturers in Global Market, 2019-2021 (Million Units)
Table 65. Global Irritable Bowel Syndrome (IBS) Capacity Market Share of Key Manufacturers, 2019-2021
Table 66. Global Irritable Bowel Syndrome (IBS) Production by Region, 2016-2021 (Million Units)
Table 67. Global Irritable Bowel Syndrome (IBS) Production by Region, 2022-2027 (Million Units)
Table 68. Irritable Bowel Syndrome (IBS) Market Opportunities & Trends in Global Market
Table 69. Irritable Bowel Syndrome (IBS) Market Drivers in Global Market
Table 70. Irritable Bowel Syndrome (IBS) Market Restraints in Global Market
Table 71. Irritable Bowel Syndrome (IBS) Raw Materials
Table 72. Irritable Bowel Syndrome (IBS) Raw Materials Suppliers in Global Market
Table 73. Typical Irritable Bowel Syndrome (IBS) Downstream
Table 74. Irritable Bowel Syndrome (IBS) Downstream Clients in Global Market
Table 75. Irritable Bowel Syndrome (IBS) Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Irritable Bowel Syndrome (IBS) Segment by Type
Figure 2. Irritable Bowel Syndrome (IBS) Segment by Application
Figure 3. Global Irritable Bowel Syndrome (IBS) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Irritable Bowel Syndrome (IBS) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Irritable Bowel Syndrome (IBS) Revenue, 2016-2027 (US$, Mn)
Figure 7. Irritable Bowel Syndrome (IBS) Sales in Global Market: 2016-2027 (Million Units)
Figure 8. The Top 3 and 5 Players Market Share by Irritable Bowel Syndrome (IBS) Revenue in 2020
Figure 9. By Type - Global Irritable Bowel Syndrome (IBS) Sales Market Share, 2016-2027
Figure 10. By Type - Global Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
Figure 11. By Type - Global Irritable Bowel Syndrome (IBS) Price (USD/K Units), 2016-2027
Figure 12. By Application - Global Irritable Bowel Syndrome (IBS) Sales Market Share, 2016-2027
Figure 13. By Application - Global Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
Figure 14. By Application - Global Irritable Bowel Syndrome (IBS) Price (USD/K Units), 2016-2027
Figure 15. By Region - Global Irritable Bowel Syndrome (IBS) Sales Market Share, 2016-2027
Figure 16. By Region - Global Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
Figure 17. By Country - North America Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
Figure 18. By Country - North America Irritable Bowel Syndrome (IBS) Sales Market Share, 2016-2027
Figure 19. US Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Irritable Bowel Syndrome (IBS) Sales Market Share, 2016-2027
Figure 24. Germany Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 25. France Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Irritable Bowel Syndrome (IBS) Sales Market Share, 2016-2027
Figure 33. China Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 37. India Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
Figure 39. By Country - South America Irritable Bowel Syndrome (IBS) Sales Market Share, 2016-2027
Figure 40. Brazil Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Irritable Bowel Syndrome (IBS) Sales Market Share, 2016-2027
Figure 44. Turkey Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2016-2027
Figure 48. Global Irritable Bowel Syndrome (IBS) Production Capacity (Million Units), 2016-2027
Figure 49. The Percentage of Production Irritable Bowel Syndrome (IBS) by Region, 2020 VS 2027
Figure 50. Irritable Bowel Syndrome (IBS) Industry Value Chain
Figure 51. Marketing Channels


More Publications